A natural variant in ANP32B impairs influenza virus replication in human cells

Ecco Staller1,2, Carol M Sheppard1, Laury Baillon1

  • 1Department of Infectious Disease, Faculty of Medicine, Imperial College London, UK.

Insights

Genetic variants in human ANP32B may offer protection against influenza. A specific ANP32B variant (rs182096718) impairs influenza virus polymerase activity, potentially reducing susceptibility to infection.

Area of Science:

  • Virology
  • Genetics
  • Immunology

Background:

  • Viral replication depends on host factors, and genetic variations in these factors influence disease susceptibility.
  • Influenza virus replication in human cells requires ANP32 proteins for the assembly of functional influenza virus polymerase (FluPol) complexes.

Purpose of the Study:

  • To investigate naturally occurring single nucleotide variants (SNVs) in human ANP32A and ANP32B genes.
  • To determine the impact of the rs182096718 SNV in ANP32B on influenza virus replication.

Main Methods:

  • Analysis of SNVs in human ANP32A and ANP32B genes.
  • Functional characterization of the ANP32B D130A substitution and its effect on FluPol activity.
  • CRISPR-edited cell models to assess viral replication.

Main Results:

  • The rs182096718 SNV in ANP32B, leading to a D130A substitution, reduces ANP32B's ability to support FluPol activity and lowers its binding affinity to FluPol.
  • ANP32B-D130A exhibits a dominant-negative effect over wild-type ANP32B and interferes with ANP32A.
  • CRISPR-edited cells expressing ANP32A and ANP32B-D130A showed attenuated FluPol activity and virus replication.

Conclusions:

  • The D130A mutation in ANP32B impairs FluPol dimer formation, leading to compromised influenza virus replication.
  • Homozygous and heterozygous carriers of the rs182096718 variant may possess genetic protection against influenza viruses.